Tasso Marketing

Facts

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Tasso Marketing

See all 4

Tasso, Inc. obtains Health Canada license and EU approvals to sell Tasso Mini in Canada, Italy, and Spain

Tasso, Inc. received Health Canada licensing and additional EU approvals allowing its Tasso Mini blood collection device to be sold in Canada, Italy, and Spain, expanding availability beyond its existing U.S. FDA 510(k) clearance and CE Marking. The Tasso Mini is designed for gentle, virtually painless sampling for sensitive or repeat-use patients and now matches the international availability of Tasso’s flagship Tasso+® device.

By Tasso Marketing

Tasso, Inc. Ranks No. 317 on 2026 Deloitte Technology Fast 500 After 200% Revenue Growth (2022–2025)

Tasso, Inc. ranked No. 317 on the 2026 Deloitte Technology Fast 500 after growing revenue 200% from 2022 to 2025, driven by demand for its patient‑centric, virtually painless at‑home blood collection devices. The company attributes growth to adoption in healthcare and clinical research, international expansion, and new regulatory clearances.